MORTALITY AND DISCHARGE LOCATION OF INTENSIVE CARE PATIENTS WITH ALZHEIMER DISEASE AND RELATED DEMENTIA

Background Intensive care unit (ICU) utilization has increased among patients with Alzheimer disease and related dementia (ADRD), although outcomes are poor. Objectives To compare ICU discharge location and subsequent mortality between patients with and patients without ADRD enrolled in Medicare Advantage. Methods This observational study used Optum's Clinformatics Data Mart Database from years 2016 to 2019 and included adults aged >67 years with continuous Medicare Advantage coverage and a first ICU admission in 2018. Alzheimer disease and related dementia and comorbid conditions were identified from claims. Outcomes included discharge location (home vs other facilities) and mortality (within the same calendar month of discharge and within 12 months after discharge). Results A total of 145 342 adults met inclusion criteria; 10.5% had ADRD and were likely to be older, female, and have more comorbid conditions. Only 37.6% of patients with ADRD were discharged home versus 68.6% of patients who did not have ADRD (odds ratio [OR], 0.40; 95% CI, 0.38-0.41). Both death in the same month as discharge (19.9% vs 10.3%; OR, 1.54; 95% CI, 1.47-1.62) and death in the 12 months after discharge (50.8% vs 26.2%; OR, 1.95; 95% CI, 1.88-2.02) were twice as common among patients with ADRD. Conclusions Patients with ADRD have lower home discharge rates and greater mortality after an ICU stay than patients without ADRD. (American Journal of Critical Care. 2023;32:249-255)